JPWO2023114485A5 - - Google Patents
Info
- Publication number
- JPWO2023114485A5 JPWO2023114485A5 JP2024534711A JP2024534711A JPWO2023114485A5 JP WO2023114485 A5 JPWO2023114485 A5 JP WO2023114485A5 JP 2024534711 A JP2024534711 A JP 2024534711A JP 2024534711 A JP2024534711 A JP 2024534711A JP WO2023114485 A5 JPWO2023114485 A5 JP WO2023114485A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- amino acid
- protein
- polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291283P | 2021-12-17 | 2021-12-17 | |
| US63/291,283 | 2021-12-17 | ||
| PCT/US2022/053196 WO2023114485A1 (en) | 2021-12-17 | 2022-12-16 | Fusion proteins comprising alpha-l-iduronidase enzymes and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546129A JP2024546129A (ja) | 2024-12-17 |
| JP2024546129A5 JP2024546129A5 (https=) | 2026-01-07 |
| JPWO2023114485A5 true JPWO2023114485A5 (https=) | 2026-01-07 |
Family
ID=85175822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534711A Pending JP2024546129A (ja) | 2021-12-17 | 2022-12-16 | アルファ－ｌ－イズロニダーゼ酵素を含む融合タンパク質及びその方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250136963A1 (https=) |
| EP (1) | EP4448746A1 (https=) |
| JP (1) | JP2024546129A (https=) |
| KR (1) | KR20240119118A (https=) |
| CN (1) | CN118401660A (https=) |
| AR (1) | AR128003A1 (https=) |
| AU (1) | AU2022415476A1 (https=) |
| CA (1) | CA3241240A1 (https=) |
| IL (1) | IL313553A (https=) |
| MX (1) | MX2024007319A (https=) |
| TW (1) | TW202340459A (https=) |
| WO (1) | WO2023114485A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202542190A (zh) * | 2023-12-20 | 2025-11-01 | 美商戴納立製藥公司 | 包含酸性α—葡萄糖苷酶之融合蛋白及其方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3218000A2 (en) * | 2014-11-10 | 2017-09-20 | Alexion Pharmaceuticals, Inc. | Therapeutic compositions of alpha-l-iduronidase, iduronate-2-sulfatase, and alpha-galactosidase a and methods of use thereof |
| TWI769982B (zh) * | 2015-06-24 | 2022-07-11 | 日商Ｊｃｒ製藥股份有限公司 | 通過血腦障壁之抗人類運鐵蛋白受體抗體 |
| WO2018152285A1 (en) | 2017-02-17 | 2018-08-23 | Denali Therapeutics Inc. | Transferrin receptor transgenic models |
| AU2018345303B2 (en) | 2017-10-02 | 2025-09-18 | Denali Therapeutics Inc. | Fusion proteins comprising enzyme replacement therapy enzymes |
| CA3101202A1 (en) * | 2018-06-18 | 2019-12-26 | Denali Therapeutics Inc. | Fusion proteins comprising progranulin |
| EP4100419A4 (en) * | 2020-02-07 | 2024-05-29 | Denali Therapeutics Inc. | METHODS OF TREATING HUNTER SYNDROME |
-
2022
- 2022-12-16 JP JP2024534711A patent/JP2024546129A/ja active Pending
- 2022-12-16 AR ARP220103478A patent/AR128003A1/es unknown
- 2022-12-16 CA CA3241240A patent/CA3241240A1/en active Pending
- 2022-12-16 US US18/719,958 patent/US20250136963A1/en active Pending
- 2022-12-16 KR KR1020247022697A patent/KR20240119118A/ko active Pending
- 2022-12-16 MX MX2024007319A patent/MX2024007319A/es unknown
- 2022-12-16 TW TW111148472A patent/TW202340459A/zh unknown
- 2022-12-16 CN CN202280083088.0A patent/CN118401660A/zh active Pending
- 2022-12-16 AU AU2022415476A patent/AU2022415476A1/en active Pending
- 2022-12-16 WO PCT/US2022/053196 patent/WO2023114485A1/en not_active Ceased
- 2022-12-16 IL IL313553A patent/IL313553A/en unknown
- 2022-12-16 EP EP22854477.1A patent/EP4448746A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533779A5 (https=) | ||
| JP2021510162A5 (https=) | ||
| JP2021113219A5 (https=) | ||
| JP2023085476A5 (https=) | ||
| US5767260A (en) | Antigen-binding fusion proteins | |
| JP2023181445A5 (https=) | ||
| JP2023040169A5 (https=) | ||
| AU2019253462B2 (en) | Growth differentiation factor 15 fusion proteins | |
| JP2017538395A5 (https=) | ||
| JPWO2019140050A5 (https=) | ||
| AU2016263808A1 (en) | Trispecific binding proteins and methods of use | |
| US20230086093A1 (en) | Mutant rsv f protein and use thereof | |
| JP2021534220A5 (https=) | ||
| JP2017529059A5 (https=) | ||
| JP2019519528A5 (https=) | ||
| JP2009536201A5 (https=) | ||
| WO2016118577A1 (en) | Thymosin-beta-four fusion proteins | |
| JP2025124718A5 (https=) | ||
| JP7676316B2 (ja) | Ｈｉｖ感染症の処置のためのクロスオーバー二重可変ドメイン（ｃｏｄｖ）フォーマットを使用した三重特異性および／または三価結合性タンパク質 | |
| JPWO2020037150A5 (https=) | ||
| JP2026035742A5 (https=) | ||
| JPWO2022094299A5 (https=) | ||
| CA3251039A1 (en) | NEW CD200 FUSION PROTEINS | |
| JPWO2020041604A5 (https=) | ||
| JPWO2023114485A5 (https=) |